The expansion of new drug modalities and growth of precision medicine create new challenges and opportunities for translational research in efforts to turn biological discoveries into beneficial therapies for patients. Leaders across the biotechnology ecosystem are pioneering novel approaches to collaboration in order to improve and accelerate the drug development process. This panel will explore a variety of these collaboration models and share their lessons learned so far.
Executive Vice Dean and Chief Scientific Officer William Wikoff Smith Professor of Cardiovascular Research Department of Medicine
Perelman School of Medicine University of Pennsylvania